Pharmacogenomics Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The pharmacogenomics market is anticipated to reach USD XXX.X million by 2034 from USD XXX.X million in 2024, at a CAGR of XX.X% during the forecast period. The study of how a patient's DNA affects how they react to medications is known as pharmacogenomics, or PGx. It alludes to a branch of pharmacology that studies how a patient's genes affect how they respond to medications. The two primary scientific fields of pharmacology and genetics are combined to form pharmacogenomics. Thanks to advancements in genetic technologies, increased demand for targeted medicines, and growing awareness of personalized medicine, the pharmacogenomics market is expanding at an incredible rate. The healthcare system faces significant challenges as a result of adverse drug reactions (ADRs), which increase patient morbidity, mortality, and healthcare expenses. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/pharmacogenomics-market Growth Driver...